Enhanced Surveillance for New Vaccine Preventable Diseases

Funding Opportunity Number: CDC-RFA-IP-16-004 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.185Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Jan 15, 2016Award Ceiling: $1,000,000Expected Number of Awards: 7Creation Date: Nov 13, 2015Funding Opportunity Description: The purpose of this announcement is to solicit applications for a research cooperative agreement that will fund a network of pediatric medical institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among asymptomatic healthy controls. Funded activities for this Core Component award will include the provision of a US pediatric vaccine-preventable (and potentially vaccine preventable) disease surveillance system for a wide variety of AGE and ARI pathogens, evaluations of vaccine effectiveness for licensed vaccines including rotavirus and influenza, burden and natural history of disease for pathogens having upcoming and/or new vaccines, pediatric infectious disease transmission dynamics, informing vaccination/therapeutic policy and development, vaccine impacts for targeted and vulnerable populations, and socioeconomic and microbiological environments potentially re...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding